Replies to post #4992 on BioCryst Pharmaceuticals,Inc. (BCRX)

[Limey42]

Way undervalued, and way below analyst price targets. Hell of a steal right now!!!!

[agribusiness72]

As expected this company is changing lives of patients and shareholders. Triple digits in 2022. 13,110 shares and counting. The excitement continues.